位置:首页 > 蛋白库 > ZN346_MOUSE
ZN346_MOUSE
ID   ZN346_MOUSE             Reviewed;         294 AA.
AC   Q9R0B7;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 139.
DE   RecName: Full=Zinc finger protein 346;
DE   AltName: Full=Just another zinc finger protein;
GN   Name=Znf346; Synonyms=Jaz, Zfp346;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF HIS-91; HIS-152; HIS-203 AND HIS-257.
RX   PubMed=10488071; DOI=10.1074/jbc.274.39.27399;
RA   Yang M., May W.S., Ito T.;
RT   "JAZ requires the double-stranded RNA-binding zinc finger motifs for
RT   nuclear localization.";
RL   J. Biol. Chem. 274:27399-27406(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C3H/He; TISSUE=Osteoblast;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Binds with low affinity to dsDNA and ssRNA, and with high
CC       affinity to dsRNA, with no detectable sequence specificity (By
CC       similarity) (PubMed:10488071). May bind to specific miRNA hairpins (By
CC       similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q9UL40,
CC       ECO:0000269|PubMed:10488071}.
CC   -!- SUBUNIT: Forms a heteromeric complex with XPO5 and ILF3. Found in a
CC       nuclear export complex with XPO5, RAN, ILF3, ZNF346 and double-stranded
CC       RNA. Interacts with XPO5. Interacts with ILF3 in an RNA-independent
CC       manner (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Cytoplasm
CC       {ECO:0000250}. Note=Nuclear at steady state, primarily in the
CC       nucleolus. Shuttles between the nucleus and cytoplasm when associated
CC       with XPO5 (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested, including heart,
CC       brain, spleen, lung, liver, muscle, kidney and testis. Exogenous
CC       expression induced apoptosis. {ECO:0000269|PubMed:10488071}.
CC   -!- DOMAIN: The zinc-finger domains are required for binding to dsRNA, and
CC       also for nuclear localization.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF083339; AAD52017.1; -; mRNA.
DR   EMBL; BC055075; AAH55075.1; -; mRNA.
DR   CCDS; CCDS26539.1; -.
DR   RefSeq; NP_036147.1; NM_012017.2.
DR   AlphaFoldDB; Q9R0B7; -.
DR   SMR; Q9R0B7; -.
DR   BioGRID; 205063; 2.
DR   STRING; 10090.ENSMUSP00000021937; -.
DR   iPTMnet; Q9R0B7; -.
DR   PhosphoSitePlus; Q9R0B7; -.
DR   EPD; Q9R0B7; -.
DR   MaxQB; Q9R0B7; -.
DR   PaxDb; Q9R0B7; -.
DR   PRIDE; Q9R0B7; -.
DR   Antibodypedia; 17273; 313 antibodies from 32 providers.
DR   DNASU; 26919; -.
DR   Ensembl; ENSMUST00000021937; ENSMUSP00000021937; ENSMUSG00000021481.
DR   GeneID; 26919; -.
DR   KEGG; mmu:26919; -.
DR   UCSC; uc007qpy.1; mouse.
DR   CTD; 26919; -.
DR   MGI; MGI:1349417; Zfp346.
DR   VEuPathDB; HostDB:ENSMUSG00000021481; -.
DR   eggNOG; ENOG502RVNK; Eukaryota.
DR   GeneTree; ENSGT00940000159101; -.
DR   InParanoid; Q9R0B7; -.
DR   OrthoDB; 1565630at2759; -.
DR   PhylomeDB; Q9R0B7; -.
DR   TreeFam; TF350019; -.
DR   BioGRID-ORCS; 26919; 0 hits in 74 CRISPR screens.
DR   ChiTaRS; Zfp346; mouse.
DR   PRO; PR:Q9R0B7; -.
DR   Proteomes; UP000000589; Chromosome 13.
DR   RNAct; Q9R0B7; protein.
DR   Bgee; ENSMUSG00000021481; Expressed in embryonic post-anal tail and 261 other tissues.
DR   ExpressionAtlas; Q9R0B7; baseline and differential.
DR   Genevisible; Q9R0B7; MM.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0019899; F:enzyme binding; ISO:MGI.
DR   GO; GO:0035198; F:miRNA binding; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:MGI.
DR   InterPro; IPR003604; Matrin/U1-like-C_Znf_C2H2.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00355; ZnF_C2H2; 4.
DR   SMART; SM00451; ZnF_U1; 4.
DR   SUPFAM; SSF57667; SSF57667; 4.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Isopeptide bond; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; RNA-binding; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..294
FT                   /note="Zinc finger protein 346"
FT                   /id="PRO_0000191810"
FT   ZN_FING         70..104
FT                   /note="Matrin-type 1"
FT   ZN_FING         131..165
FT                   /note="Matrin-type 2"
FT   ZN_FING         182..216
FT                   /note="Matrin-type 3"
FT   ZN_FING         236..270
FT                   /note="Matrin-type 4"
FT   REGION          1..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          269..294
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        20..35
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         75
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         78
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         91
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         97
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250"
FT   BINDING         136
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         139
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         152
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         158
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UL40"
FT   CROSSLNK        114
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UL40"
FT   CROSSLNK        170
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UL40"
FT   MUTAGEN         91
FT                   /note="H->A: No loss of dsRNA binding capacity. Binding
FT                   capacity was reduced 40-60%; when associated with A-203.
FT                   Binding capacity was reduced to 5-10%; when associated with
FT                   A-152 and A-203. Loss of binding capacity; when associated
FT                   with A-152; A-203 and A-257."
FT                   /evidence="ECO:0000269|PubMed:10488071"
FT   MUTAGEN         152
FT                   /note="H->A: No loss of dsRNA binding capacity. Loss of 40-
FT                   60% dsRNA binding; when associated with A-203. Binding
FT                   capacity was reduced to 5-10%; when associated with A-91
FT                   and A-203. Loss of binding capacity; when associated with
FT                   A-91; A-203 and A-257."
FT                   /evidence="ECO:0000269|PubMed:10488071"
FT   MUTAGEN         203
FT                   /note="H->A: No loss of dsRNA binding capacity. Binding
FT                   capacity was reduced 40-60%; when associated with A-91.
FT                   Binding capacity was reduced to 5-10%; when associated with
FT                   A-91 and A-152. Loss of binding capacity; when associated
FT                   with A-91; A-152 and A-257."
FT                   /evidence="ECO:0000269|PubMed:10488071"
FT   MUTAGEN         257
FT                   /note="H->A: No loss of dsRNA binding capacity. Loss of 5-
FT                   10 % dsRNA binding capacity; when associated with A-152 and
FT                   A-203. Loss of binding capacity; when associated with A-91;
FT                   A-152 and A-203."
FT                   /evidence="ECO:0000269|PubMed:10488071"
SQ   SEQUENCE   294 AA;  32698 MW;  6BD916262EDBA71E CRC64;
     MECPAPDATD AADPGEAGPY KGSEEPEGRE PDGVRFDRER ARRLWEAVSG AQPAGREEVE
     HMIQKNQCLF TSTQCKVCCA MLISESQKLA HYQSKKHANK VKRYLAIHGM ETIKGDVKRL
     DSDQKSSRSK DKNHCCPICN MTFSSPAVAQ SHYLGKTHAK SLKLKQQSTK GAALQQNREM
     LDPDKFCSLC HSTFNDPAMA QQHYMGKRHR KQETKLKLMA HYGRLADPAV SDLPAGKGYP
     CKTCKIVLNS IEQYQAHVSG FKHKNQSPKT LVTLGSQTPV QTQPTPKDSS TVQD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024